课题基金 / 基金详情

The role of Ca/calmodulin dependent protein kinase II (CaMKII) in the heart for triggering and maintenance of atrial fibrillation in diabetes mellitus

The role of Ca/calmodulin dependent protein kinase II (CaMKII) in the heart for triggering and maintenance of atrial fibrillation in diabetes mellitus
Ca/钙调蛋白依赖性蛋白激酶 II (CaMKII) 在心脏中对糖尿病心房颤动的触发和维持的作用
批准号:
321175284
负责人:
Professor Lars Maier, since 8/2019
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2016
资助国家:
德国
项目状态:
已结题
起止时间:
2015-12-31 至 2020-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diabetes mellitus (DM) is a worldwide epidemic that causes numerous cardiovascular diseases and increases mortality in patients. DM is also an independent risk factor for atrial fibrillation (AF), while the mechanisms of DM-associated AF are poorly understood. Along with the clinical importance of DM concerning increased morbidity and mortality, DM is also a pivotal social and economic problem. My previous studies and work from other groups suggest CaMKII plays a critical role in triggering and maintenance of AF. Therefore, in this research proposal I would like to study the role of oxidized CaMKII as compared to mitochondrial CaMKII for AF triggering and maintenance in DM. I will use a range of mouse models, but also human atrial heart tissue. To further decipher the mechanistic pathways I will use both in-vitro and in-vivo techniques. My hypotheses include defects of intracellular Ca homeostasis and upstream-mechanisms of CaMKII activation, but also adverse atrial remodeling, which promotes the maintenance of AF. My translational research proposal aims at identifying unknown disease pathways as well as first applications of new therapeutic concepts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
热应激通过Ca²⁺/Calcineurin/DRP1轴诱导心肌损伤与室性心律失常的分子机制研究
基于“过咸伤肾”理论探讨补肾开心散调控ENaC泛素化-Ca2+轴改善MCI神经元钙超载的机制
  • 批准号:
    JCZRLH202600550
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
FSCN1特异调控PIK3CA变异肿瘤天然免疫通路的机制研究
  • 批准号:
    2026JJ80426
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    李思思
  • 依托单位:
EB病毒核抗原1通过靶向PPP1CA稳定自身表达及其调控EBV潜伏感染的作用和机制研究
  • 批准号:
    2026JJ50144
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    卢建红
  • 依托单位: